Oxerutins
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Oxerutins is a flavonoid antioxidant indicated in the treatment of venous insufficiency and capillary fragility.
- Generic Name
- Oxerutins
- DrugBank Accession Number
- DB15826
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Synonyms
- O-(ß-hydroxyethyl) rutosides
- Oxerutine
- Oxerutins
- Oxerutins, unspecified
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Capillary fragility ••• ••• ••••• •••••••• •••• ••••••• ••• ••••••••• ••••••• ••• ••••••••••• ••••••••• •••••• Symptomatic treatment of Venous insufficiency ••• ••• ••••• •••••••• •••• ••••••• ••• ••••••••• ••••••• ••• ••••••••••• ••••••••• •••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- Paroven / Relvène / Venoruton
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
References
- General References
- AIFA Product Information: VENORUTON (oxerutins) [Link]
- External Links
- 67187
- Wikipedia
- Hydroxyethylrutoside
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Completed Prevention Deep Vein Thrombosis 1 Not Available Not Yet Recruiting Not Available Chronic Venous Diseases 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule Oral 300 MG Gel Oral 2 % Gel Topical 2 % Granule Oral 1000 MG Powder, for suspension Oral 1000 MG Solution / drops Oral 100 MG/ML Tablet Oral 1000 MG Tablet Oral 500 MG Tablet, coated Oral 500 MG Gel Topical 20 mg/g Solution / drops Oral Powder, for solution Oral 1000 mg Tablet, coated Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at September 11, 2020 18:35 / Updated at May 14, 2021 01:08